Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes.
| Publicado en: | Clinical Pharmacokinetics Vol. 64; no. 4; pp. 533 - 553 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Apr2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184826417&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184826417 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 03125963 C4U jtl: Clinical Pharmacokinetics issn: 03125963 maglogo: N pubinfo: dt: Apr2025 vid: 64 iid: 4 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 184826417 183071328 10.1007/s40262-025-01475-7 184826417 ppf: 533 ppct: 20 formats: tig: atl: Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes. aug: au: Lou, Yan-Ru Xu, Yu-Long Xiong, Yifeng Deng, Chenhui Wang, Qinghua affil: Shanghai Innogen Pharmaceutical Technology Co., Ltd., Shanghai, China sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|